California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

Weight loss drugs like Wegovy, Ozempic, and Mounjaro show transformative effects in obesity, improving heart health and reducing dementia risks. Howev ...

He prefers Mounjaro over Ozempic, another popular GLP-1 inhibitor, due to its fewer side effects and increased effectiveness.

A slimmer Elon Musk revealed on Wednesday that he uses Mounjaro, a weight-loss drug, after previously advocating for similar ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

Skyrocketing demand for Ozempic (NVO), Wegovy and other weight-loss drugs has boosted business for another line of work: ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Two large studies from the University of Southern Denmark (SDU) reveal that the diabetes drug Ozempic may double the risk of ...